Literature DB >> 17659698

Multiple pathogenic factor-induced complications of cirrhosis in rats: a new model of hepatopulmonary syndrome with intestinal endotoxemia.

Hui-Ying Zhang1, De-Wu Han, Zhong-Fu Zhao, Ming-She Liu, Yan-Jun Wu, Xian-Ming Chen, Cheng Ji.   

Abstract

AIM: To develop and characterize a practical model of Hepatopulmonary syndrome (HPS) in rats.
METHODS: The experimental animals were randomized into five feeding groups: (1) control (fed standard diet), (2) control plus intraperitoneal injection with lipopolysaccharide (LPS), (3) cirrhosis (fed a diet of maize flour, lard, cholesterol, and alcohol plus subcutaneously injection with carbon tetrachloride (CCl(4)) oil solution), (4) cirrhosis plus LPS, and (5) cirrhosis plus glycine and LPS. The blood, liver and lung tissues of rats were sampled for analysis and characterization. Technetium 99m-labeled macroaggregated albumin (Tc99m-MAA) was used to test the dilatation of pulmonary microvasculature.
RESULTS: Typical cirrhosis and subsequent hepato-pulmonary syndrome was observed in the cirrhosis groups after an 8 wk feeding period. In rats with cirrhosis, there were a decreased PaO(2) and PaCO(2) in arterial blood, markedly decreased arterial O(2) content, a significantly increased alveolar to arterial oxygen gradient, an increased number of bacterial translocated within mesenteric lymph node, a significant higher level of LPS and tumor necrosis factor-alpha (TNF-alpha) in plasma, and a significant greater ratio of Tc99m-MAA brain-over-lung radioactivity. After LPS administration in rats with cirrhosis, various pathological parameters got worse and pulmonary edema formed. The predisposition of glycine antagonized the effects of LPS and significantly alleviated various pathological alterations.
CONCLUSION: The results suggest that: (1) a characteristic rat model of HPS can be non-invasively induced by multiple pathogenic factors including high fat diet, alcohol, cholesterol and CCl(4); (2) this model can be used for study of hepatopulmonary syndrome and is clinically relevant; and (3) intestinal endotoxemia (IETM) and its accompanying cytokines, such as TNF-alpha, exert a crucial role in the pathogenesis of HPS in this model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17659698      PMCID: PMC4146787          DOI: 10.3748/wjg.v13.i25.3500

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

Review 1.  Pulmonary dysfunction in chronic liver disease.

Authors:  M B Fallon; G A Abrams
Journal:  Hepatology       Date:  2000-10       Impact factor: 17.425

Review 2.  Pulmonary-Hepatic vascular Disorders (PHD).

Authors:  R Rodríguez-Roisin; M J Krowka; Ph Hervé; M B Fallon
Journal:  Eur Respir J       Date:  2004-11       Impact factor: 16.671

Review 3.  ER stress: can the liver cope?

Authors:  Cheng Ji; Neil Kaplowitz
Journal:  J Hepatol       Date:  2006-06-15       Impact factor: 25.083

Review 4.  The hepatopulmonary syndrome.

Authors:  David T Palma; Michael B Fallon
Journal:  J Hepatol       Date:  2006-07-25       Impact factor: 25.083

5.  Hepatopulmonary syndrome in candidates for liver transplantation.

Authors:  G P Martínez; J A Barberà; J Visa; A Rimola; J C Paré; J Roca; M Navasa; J Rodés; R Rodriguez-Roisin
Journal:  J Hepatol       Date:  2001-05       Impact factor: 25.083

6.  Common bile duct ligation in the rat: a model of intrapulmonary vasodilatation and hepatopulmonary syndrome.

Authors:  M B Fallon; G A Abrams; J W McGrath; Z Hou; B Luo
Journal:  Am J Physiol       Date:  1997-04

7.  Production of superoxide and TNF-alpha from alveolar macrophages is blunted by glycine.

Authors:  M D Wheeler; R G Thurman
Journal:  Am J Physiol       Date:  1999-11

Review 8.  Hepatopulmonary syndrome. A pulmonary vascular complication of liver disease.

Authors:  M Castro; M J Krowka
Journal:  Clin Chest Med       Date:  1996-03       Impact factor: 2.878

9.  Immunomodulatory effects of glycine on LPS-treated monocytes: reduced TNF-alpha production and accelerated IL-10 expression.

Authors:  A Spittler; C M Reissner; R Oehler; A Gornikiewicz; T Gruenberger; N Manhart; T Brodowicz; M Mittlboeck; G Boltz-Nitulescu; E Roth
Journal:  FASEB J       Date:  1999-03       Impact factor: 5.191

10.  Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome.

Authors:  G A Abrams; C C Jaffe; P B Hoffer; H J Binder; M B Fallon
Journal:  Gastroenterology       Date:  1995-10       Impact factor: 22.682

View more
  14 in total

1.  Expression of the 78 kD glucose-regulated protein is induced by endoplasmic reticulum stress in the development of hepatopulmonary syndrome.

Authors:  Huiying Zhang; Minli Lv; Jiantao Jia; Zhongfu Zhao; Lili Zhang; Lina Lai; Yanjun Wu; Baohong Li; Chen Li; Jingquan Ji; Xiaoxia Tian; Yan Liu; Xujiong Li; Hui Pang; Jianhong Guo; Limin Wang; Yimin Fan; Cuiying Zhang; Dewu Han; Cheng Ji
Journal:  Gene       Date:  2013-12-12       Impact factor: 3.688

2.  Increased expression of 78 kD glucose-regulated protein promotes cardiomyocyte apoptosis in a rat model of liver cirrhosis.

Authors:  Lili Zhang; Huiying Zhang; Minli Lv; Jiantao Jia; Yimin Fan; Xiaoxia Tian; Xujiong Li; Baohong Li; Jingquan Ji; Limin Wang; Zhongfu Zhao; Dewu Han; Cheng Ji
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 3.  Alcoholic liver disease: pathogenesis and new targets for therapy.

Authors:  José Altamirano; Ramón Bataller
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-08-09       Impact factor: 46.802

4.  Effect of salvianolate on intestinal epithelium tight junction protein zonula occludens protein 1 in cirrhotic rats.

Authors:  Dan-Hong Yang; Zai-Yuan Ye; Yuan-Jun Xie; Xu-Jun He; Wen-Juan Xu; Wei-Ming Zhou
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

5.  Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.

Authors:  Yun-Xia Chen; Li-Na Lai; Hui-Ying Zhang; Yang-Hui Bi; Li Meng; Xu-Jiong Li; Xiao-Xia Tian; Li-Min Wang; Yi-Min Fan; Zhong-Fu Zhao; De-Wu Han; Cheng Ji
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

6.  A Case of Hepatopulmonary Syndrome.

Authors:  P B Sriram; R Sindhuja; M Natarajan; P S Arul Rajamurugan; B Palanikumar
Journal:  J Clin Diagn Res       Date:  2016-03-01

7.  Pentoxifylline in hepatopulmonary syndrome.

Authors:  Hamid Reza Kianifar; Maryam Khalesi; Eftekhar Mahmoodi; Monavar Afzal Aghaei
Journal:  World J Gastroenterol       Date:  2012-09-21       Impact factor: 5.742

8.  Impact of Bacterial Translocation on Hepatopulmonary Syndrome: A Prospective Observational Study.

Authors:  Ki Tae Suk; Moon Young Kim; Soung Won Jeong; Jae Young Jang; Yoon Ok Jang; Soon Koo Baik
Journal:  Dig Dis Sci       Date:  2017-12-01       Impact factor: 3.199

Review 9.  Cirrhosis and hepatopulmonary syndrome.

Authors:  Gokhan Tumgor
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

10.  Intestinal endotoxemia plays a central role in development of hepatopulmonary syndrome in a cirrhotic rat model induced by multiple pathogenic factors.

Authors:  Hui Ying Zhang; De Wu Han; Ai Rong Su; Li Tong Zhang; Zhong Fu Zhao; Jing Quan Ji; Bao Hong Li; Cheng Ji
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.